Remote Clinics and Investigations in Arrhythmia Services: What Have We Learnt During Coronavirus Disease 2019?

Código QR

Remote Clinics and Investigations in Arrhythmia Services: What Have We Learnt During Coronavirus Disease 2019?

Guardado en:

Detalles Bibliográficos
Autores principales:	Shohreh Honarbakhsh, Simon Sporton, Christopher Monkhouse, Martin Lowe, Mark J Earley, Ross J Hunter
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/c191aac78ccb4094a92d2ef518ae931f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Mobile Usability in Educational Contexts: What have we learnt?
por: Agnes Kukulska-Hulme
Publicado: (2007)

Epidemiology of COVID-19: What have we learnt until now?
por: Pekmezović Tatjana
Publicado: (2021)

Application of the Pluripotent Stem Cells and Genomics in Cardiovascular Research—What We Have Learnt and Not Learnt until Now
por: Michael Simeon, et al.
Publicado: (2021)

COVID-19 Pandemic in Lebanon: One Year Later, What Have We Learnt?
por: Jad Koweyes, et al.
Publicado: (2021)

What Have We Learnt of Joint Ventures in the Internationalization Process of Chinese Multinationals (MNCs)? Evidence from Central Africa
por: T. Dzaka-Kikouta
Publicado: (2020)

Coronavirus Disease 2019 and Cardiac Arrhythmias
por: Antoni Martínez-Rubio, et al.
Publicado: (2020)

Coronavirus Disease 2019: Where are we and Where are we Going? Intersections Between Coronavirus Disease 2019 and the Heart
por: Emilia D’Elia, et al.
Publicado: (2020)

COVID-19 pandemic. What have we learned?
por: Cristina Calvo, et al.
Publicado: (2021)

What we have learned and what the future holds: Perspectives on the COVID-19
por: Adrián Camacho-Ortiz
Publicado: (2021)

What Have We Learned about the Microbiomes of Indoor Environments?
por: Brent Stephens
Publicado: (2016)

Two decades with omalizumab: what we still have to learn
por: Incorvaia C, et al.
Publicado: (2018)

Fifteen years of new growth economics: what have we learned?
por: Sala-I-Martin, Xavier
Publicado: (2019)

Thirty years of endoscopic sinus surgery: What have we learned?
por: Bobby A. Tajudeen, et al.
Publicado: (2017)

WHAT HAVE WE EXPERIENCED WITH COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISORDERS?
por: Simge ERDEM, et al.
Publicado: (2021)

Scaling-up voluntary medical male circumcision – what have we learned?
por: Ledikwe JH, et al.
Publicado: (2014)

Trauma registries in low- and middle-income countries: Working with what we already have
por: M.R. Kesinger, et al.
Publicado: (2014)

Risk factors for immune-related adverse events: what have we learned and what lies ahead?
por: Xiaoyan Liu, et al.
Publicado: (2021)

Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop
por: Ruben D. de Ruiter, et al.
Publicado: (2021)

Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?
por: Bilal Abdulmawjood, et al.
Publicado: (2021)

Estimating maternal mortality: what have we learned from 16 years of surveys in Afghanistan?
por: Sandra Alba, et al.
Publicado: (2020)

Contradictions regarding teaching and writing (or writing to learn) in the disciplines: What we have learned in the USA
por: David R. Russell
Publicado: (2013)

Transmission of Ebola Viruses: What We Know and What We Do Not Know
por: Michael T. Osterholm, et al.
Publicado: (2015)

Editorial: The Sustainable Development Report 2019: What can We do to Address the Challenges?
por: Anne Gaskell
Publicado: (2019)

Pulmonary rehabilitation in Lebanon "What do we have"? A national survey among chest physicians.
por: Rebecca Farah, et al.
Publicado: (2021)

Psychogenic nonepileptic seizures: a treatment review. What have we learned since the beginning of the millennium?
por: Baslet G
Publicado: (2012)

WHAT DO WE PAY ATTENTION WHEN HAVING FOOD: PRE-SERVICE SCIENCE TEACHERS’ CASE
por: Sibel DEMİR, et al.
Publicado: (2019)

Public spending and the poor: what we know, what we need to know
por: Van de Walle, Dominique
Publicado: (2014)

Could an open-source clinical trial data-management system be what we have all been looking for?
por: Greg W Fegan, et al.
Publicado: (2008)

Turning genes into medicines—what have we learned from gene therapy drug development in the past decade?
por: Katherine A. High
Publicado: (2020)

Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?
por: Mahendra Rai, et al.
Publicado: (2021)

What we see Depends on How we Move
por: Francesca Forlé
Publicado: (2016)

What can be learnt from a qualitative evaluation of implementing a rapid sexual health testing, diagnosis and treatment service?
por: Joanna M Kesten, et al.
Publicado: (2021)

A Decade of Mighty Lipophagy: What We Know and What Facts We Need to Know?
por: Muhammad Babar Khawar, et al.
Publicado: (2021)

On What We Experience When We Hear People Speak
por: Anders Nes
Publicado: (2017)

Innovation and entrepreneurship in Latin America: What do we know? What would we like to know?
por: Alvarez,Roberto, et al.
Publicado: (2018)

Correction for Osterholm et al., Transmission of Ebola Viruses: What We Know and What We Do Not Know
por: Michael T. Osterholm, et al.
Publicado: (2015)

“This is streets ahead of what we used to do”: staff perceptions of virtual clinical pharmacy services in rural and remote Australian hospitals
por: Julaine Allan, et al.
Publicado: (2021)

Prediabetes: what are we talking about?
por: Escalada San Martín Javier
Publicado: (2021)

Stanley Cavell on What We Say
por: Arata Hamawaki
Publicado: (2021)

A decade of inflation targeting in the world: what do we know and what do we need to know?
por: Mishkin, Frederic S., et al.
Publicado: (2019)